Shockwave Therapy for ED: Does It Actually Work?

Shockwave therapy for ED is marketed as the closest thing to a cure — a treatment that fixes the underlying problem rather than masking it for four hours at a time. Clinics charge accordingly. The evidence, now that a large body of it exists, is considerably more restrained than the sales pitch.

Here is what the trials actually found, what the urology guidelines say, and how to decide whether it is worth your money.

What Shockwave Therapy Is

Low-intensity extracorporeal shockwave therapy — LiSWT or LI-ESWT — delivers acoustic pressure waves to the shaft and crura of the penis through a handheld probe. The energy is a fraction of what is used to break up kidney stones. Sessions run about 15 to 20 minutes, a course is typically six to twelve sessions over several weeks, and no anaesthetic is needed.

The proposed mechanism is neoangiogenesis — the idea that controlled micro-stress on tissue triggers growth factor release, which in turn stimulates new blood vessel formation and recruits endothelial progenitor cells. If that works as described, it would improve arterial inflow at the source rather than temporarily amplifying a signal the way a PDE5 inhibitor does.

That is a genuinely appealing premise. The question is whether the clinical results match it.

What the Evidence Shows

The most rigorous assessment available is the 2025 Cochrane review by Ergun and colleagues, which pooled 21 randomised controlled trials covering 1,357 men.

The headline numbers:

• Short term (3 months or less): erectile function improved by a mean difference of 3.89 points on the IIEF-EF scale versus sham, 95% CI 2.89 to 4.89.
• Long term (beyond 3 months): a mean difference of 5.25 points.
• Certainty of evidence: low, for both.

The 3.89 figure needs context to be meaningful. Researchers use a minimal clinically important difference of around 4 points on IIEF-EF — the threshold below which a change is statistically detectable but unlikely to be something a man actually notices in his life. The short-term result sits just under that line. The longer-term result clears it, but rests on fewer trials and the same low-certainty rating.

An umbrella review of the existing systematic reviews reached a similar position: signal present, quality inconsistent.

The recurring methodological complaint is heterogeneity. Trials used different machines, different energy flux densities, different session counts, different pulse totals, and different outcome measures. A 2024 analysis in the International Journal of Impotence Research argued that protocols should be matched to ED severity — an implicit acknowledgement that the field has not settled on what the treatment even is.

What the Guidelines Say

This is where the gap between clinic marketing and professional consensus is widest.

The American Urological Association classes low-intensity shockwave therapy as investigational in its erectile dysfunction guideline, a conditional recommendation, and advises that it be used under an institutional review board approved protocol rather than as routine care. It is not FDA approved for this indication.

The European Association of Urology is slightly more permissive, allowing that LiSWT may be used in men with mild organic ED or poor response to PDE5 inhibitors — but attaches a weak strength of recommendation, explicitly citing the heterogeneity problem. A published analysis of guideline recommendations and evidence quality documents how far routine clinical use has run ahead of what the guidelines actually support.

Translation: if a clinic tells you this is an established, proven treatment, that is not what the specialty bodies have concluded.

Who It Might Reasonably Help

The mechanism only makes sense for one type of ED. Shockwave therapy targets blood vessel growth, so it can only help men whose problem is arterial inflow.

Plausible candidates:

• Mild, vasculogenic ED
• Poor responders to PDE5 inhibitors who want to try something before injections or implants
• Men enrolled in a properly designed clinical trial

Unlikely to benefit:

• ED driven primarily by low testosterone, medication side effects, or depression
• Neurogenic ED from diabetes with established neuropathy or spinal injury
• Venous leak and weak pelvic floor mechanics — where blood arrives fine but does not stay under pressure

That last category is the one most often missed, and it is worth understanding before spending thousands.

The Mechanism Shockwave Cannot Address

An erection has two halves. Blood has to arrive, and blood has to stay. Shockwave therapy only addresses the first.

The second half is muscular. The ischiocavernosus and bulbospongiosus muscles wrap the base of the penis. When they contract, they compress the crura and the deep dorsal vein, sealing blood inside the erectile tissue and driving intracavernosal pressure well above what arterial inflow alone can produce. That is the difference between filled and rigid. If those muscles are weak, an erection that starts well fades — and no amount of new arterial capacity fixes an outflow problem.

The evidence for training them is stronger than the shockwave data, and considerably more certain. Dorey and colleagues ran a randomised controlled trial published in BJU International in 2004 comparing pelvic floor muscle exercises against lifestyle advice in men with ED. At six months, 40% of the exercise group had regained normal erectile function and a further 35.5% had improved significantly. A 2025 narrative review in the International Journal of Impotence Research supports pelvic floor physical therapy across erectile and ejaculatory complaints.

Set the two side by side. One is a low-certainty mean difference that may sit below the noticeable threshold, costing thousands. The other restored normal function in four men out of ten, costs nothing, and has no side effects.

If you are unsure whether you can even isolate these muscles, pelvic floor exercises for men covers the cues before you start counting reps.

A Sensible Order of Operations

1. Get a cause identified. Persistent ED is a cardiovascular signal. Bloods, blood pressure, and a proper history come before any treatment decision. The NIDDK treatment overview is a useful map of the standard pathway.
2. Fix the vascular inputs. Blood pressure, blood sugar, waist circumference, smoking, weekly alcohol. These move erectile function more than any procedure.
3. Train the pelvic floor for twelve weeks. Free, evidence-backed, and it addresses the half of the mechanism shockwave cannot touch.
4. Try PDE5 inhibitors properly. Many men labelled "non-responders" were never dosed or counselled correctly. ED medication covers what proper use looks like.
5. Only then consider shockwave. And if you do, ask the clinic which protocol they use, how many pulses, what energy flux density, and what published trial that matches. A clinic that cannot answer is improvising.

What Progress Looks Like Without It

• Week 2–4: Pelvic floor contractions get measurably stronger. Morning erections are the earliest honest signal of vascular change because they bypass psychology.
• Week 6–8: Erection firmness starts shifting. Men who fixed sleep and alcohol alongside the training see it sooner.
• Week 12: The trial window. This is where the Dorey results landed, and where you have enough information to judge whether you need medical escalation.
• No change by 12 weeks: Genuinely useful information. That is the point to escalate to a urologist rather than the point to start with an investigational treatment. Erectile dysfunction treatment lays out the full ladder of options in order.

The Short Version

Shockwave therapy for ED has a real but small effect, rated low-certainty, sitting near the edge of what men would notice. The AUA calls it investigational. The EAU allows it weakly, for a narrow group. It is not FDA approved, insurance will not cover it, and courses run into the thousands.

It may eventually earn a place as protocols standardise. Right now it is not the first thing to spend money on — especially when the muscular half of the erection mechanism has better evidence, costs nothing, and most men have never trained it.